RA CAPITAL MANAGEMENT, L.P. - 24 Mar 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P
Issuer symbol
ETNB
Transactions as of
24 Mar 2023
Net transactions value
+$39,999,992
Form type
4
Filing time
30 Mar 2023, 17:00:15 UTC
Previous filing
27 Mar 2023
Next filing
30 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Purchase $39,999,992 +2,461,538 +29% $16.25 11,081,584 24 Mar 2023 See Footnotes F1, F2, F4
holding ETNB Common Stock 335,364 24 Mar 2023 See Footnotes F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the Securities and Exchange Commission on March 27, 2023.
F2 Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund").
F3 Held directly by the RA Capital Nexus Fund, L.P. (the "Nexus Fund").
F4 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.